期刊文献+

胰腺腺管内上皮瘤的研究进展

Progress in the study of pancreatic intraepithelial neoplasia
下载PDF
导出
摘要 胰腺癌的早期诊断与综合治疗目前缺乏有效的措施,80%的胰腺癌在诊断时已丧失手术机会,5年生存率仅为0.4%~4%。胰腺癌生存时间的延长取决于早发现、早治疗。故充分认识胰腺癌的癌前病变一胰晾腺管内上皮瘤(PanlN),了解其病理分级及与之相关的各级分子生物学水平的改变,讨论PanlN红胰腺癌形成中的作用,对胰腺癌的早期诊断及综合治疗有重要意义。 Now we lack methods of the early diagnosis and effective treatment in pancreatic cancer. Eighty percent of pancreatic cancer patients have unresectable at the time of diagnosis and only 0.4% - 4% patients will be alive at five years. The decteciton of pancratic neoplasia at an early, and thererfore potentially curable, stage remains the best possiblility for improving patient survival at the present time. Recently evidence suggests that pancreatic intraepithelial neoplasia(PanIN) lesions are the nonivasive precursors for invasive ductal adenocarcinomas. A comprehensive review of the pathological stages and molecular changes of PanlNs provides a platform to study the pancreatic cancer progression model.
出处 《胃肠病学和肝病学杂志》 CAS 2008年第9期706-708,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 胰腺腺管内上皮瘤 病理分级 细胞表型 分子事件 Pancreatic intraepithelial neoplasia Pathological stages Cellular phenotypes Molecular events
  • 相关文献

参考文献3

二级参考文献93

  • 1[1]Quinn M,Babb P,Brock A.Kirby L,Jones J.Cancer trends in England and Wales 1950-1999.London:Office for national statistics,2001:340
  • 2[2]Jemal A,Murray T,Samuels A,Ghafoor A,Ward E,Thun MJ.Cancer statistics,2003.CA Cancer J Clin 2003; 53:5-26
  • 3[3]Li D,Xie K,Wolff R,Abbruzzese JL.Pancreatic cancer.Lancet 2004; 363:1049-1057
  • 4[4]Hruban RH,Wilentz RE,Kern SE.Genetic progression in the pancreatic ducts.Am J Pathol 2000; 156:1821-1825
  • 5[5]Tada M,Ohashi M,Shiratori Y,Okudaira T,Komatsu Y,Kawabe T,Yoshida H,Machinami R,Kishi K,Omata M.Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease.Gastroenterology 1996;110:227-231
  • 6[6]Moskaluk CA,Hruban RH,Kern SE.p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.Cancer Res 1997; 57:2140-2143
  • 7[7]Terhune PG,Phifer DM,Tosteson TD,Longnecker DS.K-ras mutation in focal proliferative lesions of human pancreas.Cancer Epidemiol Biomarkers Prev 1998; 7:515-521
  • 8[8]Day JD,Digiuseppe JA,Yeo C,Lai-Goldman M,Anderson SM,Goodman SN,Kern SE,Hruban RH.Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms.Hum Pathol 1996; 27:119-124
  • 9[9]Yamano M,Fujii H,Takagaki T,Kadowaki N,Watanabe H,Shirai T.Genetic progression and divergence in pancreatic carcinoma.Am J Pathol 2000; 156:2123-2133
  • 10[10]Hameedm,Marrero AM,Conlon KC.Expression of p53 nucleoprotein in situ pancreatic ductal adenocarcinoma:an immunohistochemical analysis of 100 cases.Lab Investig 1994;70:132A

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部